Top Markets
Coin of the day
Spago Nanomedical AB (publ) Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)

SPAGO
Rangering i aksjer #32285
Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to... Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gadolinium-free MRI contrast agent developed for imaging breast and pancreatic cancers; and the Tumorad project, which is advancing SN201, a radionuclide therapy intended for managing advanced and metastatic forms of cancer. Originally established as Spago Imaging AB (publ), the company adopted its current name, Spago Nanomedical AB (publ), in May 2014. Founded in 1999, its base of operations is situated in Lund, Sweden.
Aksjekurs
$0.01317984
Sist synkronisert: 2026-08-17
Markedsverdi
$10.52M
Endring (1 dag)
-1.26%
Endring (1 år)
-53.51%
Land
SE
Handel Spago Nanomedical AB (publ) (SPAGO)

Kategori

EPS for Spago Nanomedical AB (publ) (SPAGO)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Spago Nanomedical AB (publ) er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Spago Nanomedical AB (publ) fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter